On the other hand, XFC exerts its therapeutic effects by regulating FTO to upregulate the m6A level of ENST00000619282, thereby inhibiting the NF-κB pathway activation, suppressing apoptosis evasion in co-cultured RA-FLS, and inhibiting immune-inflammatory responses. Here, NFKB1 is linked to rheumatoid arthritis.